With an initial investment of over 17 million euros for the development of 5,600 square meters of new laboratories dedicated to pharmaceutical technology and analytical chemistry, Alfasigma confirms its commitment to Research and Development. L’inauguration of ‘Labio 4.0 Marino Golinelli’, this morning in the Pomezia pharmaceutical group plant, is part of a broader corporate strategy of progressive investment in R&D, which allows Alfasigma, one of the top five pharmaceutical companies with Italian capital, to stand out both nationally and internationally for innovation and technological development.
Read Also
- Listen to TV on Wednesday 14 July: Superquark, Men and Women the choice Jul 15, 2021
- Men and women, goodbye Vanessa and Massimiliano: what a disappointment Aug 26, 2021
- Sean Connery’s last public image Oct 31, 2020
- Gisela Valcárcel: her misogynistic comment prior to the presentation of Korina Rivadeneira Aug 29, 2021
- Croem opens a way for dialogue, but hundreds of students will continue today without a school bus Sep 9, 2021
- For the third time they kidnap Irenio Bohórquez, a farmer from Ocaña, Norte de Santander Jun 4, 2022
- Bancentral Volunteering strengthens its solidarity projects Jun 1, 2022